Study S001838

Kinetic Study of Human Pharmacokinetics in Normal Renal Function, and Renal Insufficiency Subject of Polyethylene Glycol Loxenatide (PEX168)(Open, Non-randomized, Parallel-group)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02467790
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: UNKNOWN
Enrollment: 24
Start: 2015-02
Primary completion: 2016-03
Lead sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:PEX168
Results posted: FALSE

Registered primary outcomes

Pharmacokinetic index [Baseline to Day31]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0009843	Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study. Wang J, British journal of clinical pharmacology	2019	Other trial	PMID 31396983 DOI	cites ClinicalTrials.gov:NCT02467790; registry reference DERIVED:31396983